跳至主要内容
临床试验/PACTR202312551082722
PACTR202312551082722尚未招募2 期

Severe Malaria A Research and Trials consortium - Multisite Adaptive Platform trial SMAART-MAP trial

Imperial College0 个研究点目标入组 450 人开始时间: 2023年11月13日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
450

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 Month(s) 至 23 Month(s)(—)
性别
All

入选标准

  • Admitted to the paediatric ward in the last 24 hours
  • Current or recent evidence of malaria (slide or rapid diagnostic test (RDT) positive in this admission)
  • Guardian willing to provide consent
  • Domain Specific criteria
  • Cerebral Malaria Domain
  • EITHER One or more reported seizures in the current episode of illness and altered consciousness (BCS=4) at screening
  • OR Presence of coma (BCS =2) at screening regardless of history
  • Renal domain
  • Creatinine >1.5xULN on point-of-care assay at screening
  • Meet one of the current WHO severity criteria (clinical or laboratory (where these tests are done routinely)) (Group 1 and 2 from the recent WHO reclassification of severe malaria)
  • Anaemia Domain
  • One or more or the following severity signs: Hb<4g/dl, prostration, impaired consciousness, respiratory distress, history of passing red or coca-coloured urine in this illness

排除标准

  • Domain Specific criteria
  • Cerebral Malaria Domain
  • Received an anticonvulsant within 6 hours of screening or between screening and randomisation.
  • Known cerebral palsy or significant neuro-development delay.
  • Renal Domain
  • Received paracetamol within 6 hours of screening or between screening and randomisation
  • Known allergy to paracetamol
  • Severe malnutrition (middle upper arm circumference MUAC<11.5cm)
  • Anaemia Domain
  • Known congenital or valvular heart disease (not surgically corrected)

研究者

发起方
Imperial College

相似试验

Severe Malaria A Research and Trials consortium -... | 临床试验